Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperoxic-hyperbaric HIT for Altitude Performance
NCT02356900Phase 2Terminated
- Sponsor
- Duke University
- Start
- Feb 2015
- Primary completion
- May 2016
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial (2 arms), sponsored by Duke University. Primary endpoints: Maximum Aerobic Capacity, Ventilatory Threshold and 5 more. Started Feb 2015; status: terminated.
Beyond the preview
Go deeper on NCT02356900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02356900.